Rhythm Pharmaceuticals Inc (RYTM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2024 | 09-2024 | 06-2024 | 03-2024 | 12-2023 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -260,602 | -217,310 | -173,633 | -141,372 | -184,678 |
| Depreciation Amortization | 1,563 | 1,180 | 795 | 405 | 1,758 |
| Accounts receivable | -3,645 | -4,439 | -2,731 | 172 | -8,643 |
| Accounts payable and accrued liabilities | 21,918 | 6,739 | -769 | -1,251 | 14,773 |
| Other Working Capital | 10,575 | 367 | -4,334 | -2,188 | 4,807 |
| Other Operating Activity | 116,312 | 118,429 | 110,853 | 103,491 | 35,826 |
| Operating Cash Flow | $-113,879 | $-95,034 | $-69,819 | $-40,743 | $-136,157 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -7,673 | -28,830 | 61,488 | 70,050 | 49 |
| PPE Investments | -40,500 | -40,500 | -40,000 | -40,000 | -5,714 |
| Investing Cash Flow | $-48,173 | $-69,330 | $21,488 | $30,050 | $-5,665 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | N/A | N/A | N/A | 24,370 |
| Debt Repayment | -12,900 | -9,092 | -5,756 | -2,783 | -7,398 |
| Common Stock Issued | 56,392 | 14,256 | 8,428 | 7,026 | 57,396 |
| Other Financing Activity | 147,750 | 147,750 | 147,750 | 0 | 0 |
| Financing Cash Flow | $191,242 | $152,914 | $150,422 | $4,243 | $74,368 |
| Exchange Rate Effect | 2 | -975 | -372 | -71 | -142 |
| Beginning Cash Position | 60,409 | 60,409 | 60,409 | 60,409 | 128,005 |
| End Cash Position | 89,601 | 47,983 | 162,128 | 53,888 | 60,409 |
| Net Cash Flow | $29,192 | $-12,426 | $101,719 | $-6,521 | $-67,596 |
| Free Cash Flow | |||||
| Operating Cash Flow | -113,879 | -95,034 | -69,819 | -40,743 | -136,157 |
| Capital Expenditure | -40,500 | -40,500 | -40,000 | -40,000 | -5,714 |
| Free Cash Flow | -154,379 | -135,534 | -109,819 | -80,743 | -141,871 |